AXSM Insider Trading Activity and SEC Form 4 Filings
AXSM insider trading summary
Over the past 12 months, insiders at Axsome Therapeutics, Inc. (AXSM) reported 29 sales worth $111.1M by 8 insiders and no open-market purchases on SEC Form 4. Net insider selling was $111.1M.
Latest AXSM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Mark L. Jacobson | Chief Operating Officer | Sell | $2.1M (10,000 @ $208.65) |
| Aug 6, 2026 | Herriot Tabuteau | Chief Executive Officer | Sell | $997K (4,660 @ $213.95) |
| Aug 5, 2026 | Herriot Tabuteau | Chief Executive Officer | Sell | $9.5M (45,004 @ $212.01) |
| Jul 1, 2026 | Herriot Tabuteau | Chief Executive Officer | Sell | $11.9M (49,666 @ $240.25) |
| Jun 11, 2026 | Roger Jeffs | Insider | Sell | $71K (286 @ $249.12) |
| Jun 10, 2026 | Mark Coleman | Insider | Sell | $160K (643 @ $249.00) |
| Jun 10, 2026 | Roger Jeffs | Insider | Sell | $70K (286 @ $246.18) |
| Jun 10, 2026 | Susan Mahony | Insider | Sell | $74K (300 @ $246.18) |
| Jun 9, 2026 | Herriot Tabuteau | Chief Executive Officer | Sell | $12.0M (49,670 @ $241.01) |
| Jun 9, 2026 | Susan Mahony | Insider | Sell | $71K (300 @ $237.21) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.